Glanbia plc (LON:GLB - Get Free Report) insider Hugh McGuire sold 42,719 shares of the firm's stock in a transaction on Friday, March 28th. The shares were sold at an average price of GBX 1,055 ($13.82), for a total value of £450,685.45 ($590,520.77).
Glanbia Price Performance
LON:GLB traded down GBX 0.18 ($0.00) on Friday, hitting GBX 9.92 ($0.13). The company had a trading volume of 111,571 shares, compared to its average volume of 50,389. Glanbia plc has a 52 week low of GBX 9.65 ($0.13) and a 52 week high of GBX 19.62 ($0.26). The stock has a market capitalization of £2.53 billion, a price-to-earnings ratio of 19.68, a PEG ratio of 8.32 and a beta of 0.47. The firm has a 50 day moving average of GBX 12.37 and a two-hundred day moving average of GBX 13.86. The company has a current ratio of 1.63, a quick ratio of 0.86 and a debt-to-equity ratio of 48.90.
Glanbia Increases Dividend
The company also recently disclosed a dividend, which will be paid on Friday, May 2nd. Shareholders of record on Thursday, March 20th will be issued a €0.23 ($0.26) dividend. This is an increase from Glanbia's previous dividend of $0.16. The ex-dividend date of this dividend is Thursday, March 20th. This represents a yield of 2.18%. Glanbia's dividend payout ratio is 7,340.94%.
About Glanbia
(
Get Free Report)
We are a better nutrition company, home to consumer brands and ingredients that help people around the world feel strong, nourished, and to perform well at any age. Everything we do has real nutritional benefit. Everything we do is in pursuit of better, for each other and the planet.
Read More
Before you consider Glanbia, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Glanbia wasn't on the list.
While Glanbia currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.